New live mycobacterial vaccines: the Geneva consensus on essential steps towards clinical development

This publication has 19 references indexed in Scilit:

• Long-Term Protection against Tuberculosis following Vaccination with a Severely Attenuated Double Lysine and Pantothenate Auxotroph ofMycobacterium tuberculosis
  Infection and Immunity, 2005
• Enhanced Protection against Tuberculosis by Vaccination with RecombinantMycobacterium microtiVaccine That Induces T Cell Immunity against Region of Difference 1 Antigens
  The Journal of Infectious Diseases, 2004
• IS 6110 Mediates Increased Transcription of the phoP Virulence Gene in a Multidrug-Resistant Clinical Isolate Responsible for Tuberculosis Outbreaks
  Journal of Clinical Microbiology, 2004
• Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis
  Nature Medicine, 2003
• A New Vaccine against Tuberculosis Affords Greater Survival after Challenge than the Current Vaccine in the Guinea Pig Model of Pulmonary Tuberculosis
  Infection and Immunity, 2003
• A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis
  Nature Medicine, 2002
• How can immunology contribute to the control of tuberculosis?
  Nature Reviews Immunology, 2001
• Comparative Evaluation of Low-Molecular-Mass Proteins fromMycobacterium tuberculosisIdentifies Members of the ESAT-6 Family as Immunodominant T-Cell Antigens
  Infection and Immunity, 2000
• Global Burden of Tuberculosis
  JAMA, 1999
• Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature
  JAMA, 1994